Article info
PDFOriginal article
Nuclear survivin is associated with cell proliferative advantage in uterine cervical carcinomas during radiation therapy
- Correspondence to Professor Makoto Saegusa, Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan; msaegusa{at}med.kitasato-u.ac.jp
Citation
Nuclear survivin is associated with cell proliferative advantage in uterine cervical carcinomas during radiation therapy
Publication history
- Accepted January 3, 2012
- First published March 3, 2012.
Online issue publication
September 21, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.